4DCT and respiratory motion management strategies in lung cancer radiotherapy
About the Presentation
This seminar on motion management and 4DCT will cover on the following areas:
- What is respiratory motion and the extent of the problem;
- The relevance of respiratory motion to radiotherapy treatment planning;
- Specific methods of dealing with respiration motion during radiotherapy imaging and treatment delivery.
On completing this seminar participants should:
- Be aware of the magnitude of respiratory motion present;
- Be familiar with the various respiratory motion management techniques that may reduce dos to normal tissues and improve the accuracy of target volume delineation;
- Be familiar with the concept of 4DCT acquisition;
- Appreciate why motion management is essential for the implementation of stereotactic ablative body radiotherapy (SABR) treatments in lung cancer.
About the Author
Dr Gerry Hanna
Dr Gerry Hanna is Consultant Clinical Oncologist and Senior Lecturer at the Centre for Cancer Research and Cell Biology, Queen’s University of Belfast. He is involved in the treatment of lung and breast cancer, both with systemic therapy and radiation therapy. He completed a PhD fellowship in 2010 on the topic of PET/CT for target volume delineation in the radiotherapy planning process for patients with lung cancer. In addition to PET/CT for radiation treatment planning his research interests include the use of IMRT in lung cancer, stereotactic radiotherapy for lung cancer, altered fractionation in breast cancer and the use of predictive assays.